RSS expresses displeasure at extravagant praise of PM Modi as God's gift'

Bengaluru, May 21: With temples yet to open for devotees as coronavirus restrictions are in place, the Karnataka government is preparing for live streaming of sevas (service) and poojas offered to deities at temples that comes under the state's Hindu Religious Institutions and Charitable Endowment Department.

The government has also decided to develop an app and web-based software with an intention to provide information to devotees regarding temples, also to facilitate online donations and advance booking for various sevas offered there.

Regarding online live streaming, Commissioner of the Hindu Religious Institutions and Charitable Endowment Department has written to the Deputy Commissioners of all the districts and Executive Officers seeking a list of temples that comes under their jurisdiction where such facility can be provided.

"It has been intended to do online live streaming of sevas and pooja rituals at temples that come under the department in the backdrop of COVID-19 crisis. In this regard it is requested to provide a list of temples where online live facility can be provided to devotees, by abiding the traditions and practices of the temple," the letter said.

Though the temples are holding daily poojas and rituals, they are not open to public for now, with COVID-19 induced lockdown restrictions in place.

Officials had recently had stated that the department was planning to have a standard operating procedure (SOP) in place, that needs to be followed at temples in a post lockdown scenario, once they are opened for the public.

There are over 34,000 temples in the state that come under the department.

Meanwhile, in another letter to DCs of 15 districts, also Executive officers and administrators of 'A' grade temples, aimed at development of app and web-based software, the Commissioner has sought information regarding sevas offered at temples in their jurisdictions and those sevas for which option can be provided for devotees to do advance booking.

Mysuru, Jan 2: Mysuru-based Karnataka State Open University is gearing up to offer courses online from this year onwards and a proposal in this connection will be placed before the University Grants Commission (UGC) this month, after approval from the board of management.

As of now, the university offers 31 courses, including undergraduate, postgraduate, and diploma programmes.

Vice-chancellor Vidyashankar S Said that the university will submit its proposal to the UGC soon.

“This is being done to make learning convenient and help students study their courses of choices from the comfort of their homes.”

After launching online admissions for courses, this is another step to go paperless and towards an e-campus, the V-C explained.

The university has also proposed to launch 12 new courses for 2020-21.

A proposal in this regard will be placed before the board for approval on Thursday and the same will be submitted to the UGC for its nod.

Prof. Vidyashankar said the these courses will be in addition to the 31 already available.

The new courses include LLM, MA in Education, BBA, BSc, BCA, diploma in Information Technology, postgraduate diploma in Information Technology, BSc in Information Technology, MSc in Information Technology, MSc in Botany, PG diploma in Banking and Insurance, MSc in Zoology, MA in Telugu, Executive MBA, and MSc in Food Sciences and Nutrition.

The new courses had been proposed based on students’ feedback and the trend.

The V-C said the admissions for the January cycle have begun and over 380 students had so far taken admissions online.

“We are hoping for good admissions this cycle and are expecting around 12,000 admissions,” he replied.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.